New Delhi: In yet another boost to India’s vaccination spree, the Drugs Controller General of India (DCGI) has given emergency use approval to Bharat Biotech’s vaccine – Covaxin – for children aged between 12-18 years, official sources told ABP News.
The vaccine of Bharat Biotech was trialed in children in phases 2 and 3 and the subject expert committee had recommended it to be given to children.
The vaccine trial was divided into three age groups: 2 to 6, 6 to 12 and 12 to 18 years.
Covaxin is already included in the vaccination program and is being given to people over the age of 18.
(This is a developing story. More details awaited.)
Check out below Health Tools-
Calculate Your Body Mass Index ( BMI )
.